Effect of Radiotherapy Volume and Dose on Secondary Cancer Risk in Stage I Testicular Seminoma

International Journal of Radiation Oncology Biology Physics

Volumn 70, Issue 3, 2008, Pages 853-858

  Zwahlen, Daniel R ^a,b   Martin, Jarad M ^c   Millar, Jeremy L ^b   Schneider, Uwe ^d  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b ALFRED HOSPITAL   (Australia)

^c Radiation Oncology Queensland   (Australia)

^d TRIEMLI HOSPITAL   (Switzerland)

Author keywords

Comparative treatment planning; OED; Organ equivalent dose; Para aortic radiotherapy; Secondary cancer; Seminoma

Indexed keywords

DOSIMETRY; HEALTH RISKS; PATIENT MONITORING; RADIOTHERAPY; TUMORS;

COMPARATIVE TREATMENT PLANNING; ORGAN EQUIVALENT DOSES; PARA-AORTIC RADIOTHERAPY; SECONDARY CANCER; SEMINOMA;

ONCOLOGY;

AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CASE REPORT; COMPARATIVE STUDY; DOSE CALCULATION; DOSE RESPONSE; HUMAN; MALE; METASTASIS; PHOTON; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; SEMINOMA; STATISTICAL MODEL;

ADULT; AGE FACTORS; AGED; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; LINEAR MODELS; MALE; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; PHANTOMS, IMAGING; RADIOTHERAPY DOSAGE; RISK ASSESSMENT; SEMINOMA; TESTICULAR NEOPLASMS;

EID: 39049130140     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.10.007     Document Type: Article

References (31)

1. de Wit R., and Fizazi K. Controversies in the management of clinical stage I testis cancer. J Clin Oncol 24 (2006) 5482-5492
2. Horwich A., Shipley J., and Huddart R. Testicular germ-cell cancer. Lancet 367 (2006) 754-765
3. Travis L.B., Fossa S.D., Schonfeld S.J., et al. Second cancers among 40,576 testicular cancer patients: Focus on long-term survivors. J Natl Cancer Inst 97 (2005) 1354-1365
4. van Leeuwen F.E., Stiggelbout A.M., van den Belt-Dusebout A.W., et al. Second cancer risk following testicular cancer: A follow-up study of 1,909 patients. J Clin Oncol 11 (1993) 415-424
5. Vudarla N., Jawed I., Kaya H., et al. Survival and secondary malignancy rates for adjuvant radiation therapy versus observation in stage I testicular seminoma: A Surveillance, Epidemiology, and End Results (SEER) analysis. Presented at the 43rd Annual Meeting of the American Society of Clinical Oncology. Part I. J Clin Oncol 25 Suppl. 18 (2007) 240s
6. Hanks G.E., Peters T., and Owen J. Seminoma of the testis: Long-term beneficial and deleterious results of radiation. Int J Radiat Oncol Biol Phys 24 (1992) 913-919
7. Fossa S.D., Horwich A., Russell J.M., et al., Medical Research Council Testicular Tumor Working Group. Optimal planning target volume for stage I testicular seminoma: A Medical Research Council randomized trial. J Clin Oncol 17 (1999) 1146-1154
8. Warde P., Gospodarowicz M.K., Panzarella T., et al. Stage I testicular seminoma: Results of adjuvant irradiation and surveillance. J Clin Oncol 13 (1995) 2255-2262
9. Jones W.G., Fossa S.D., Mead G.M., et al. Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I testicular seminoma: A report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328). J Clin Oncol 23 (2005) 1200-1208
10. Schneider U., Zwahlen D., Ross D., et al. Estimation of radiation-induced cancer from three-dimensional dose distributions: Concept of organ equivalent dose. Int J Radiat Oncol Biol Phys 61 (2005) 1510-1515
11. Zubal I.G., Harrell C.R., Smith E.O., et al. Computerized three-dimensional segmented human anatomy. Med Phys 21 (1994) 299-302
12. White R.L., and Maier J.G. Testis tumors. In: Perez C.A., and Brady L.W. (Eds). Principles and practice of radiation oncology (1987), JB Lippincott, Philadelphia 899-911
13. Kiricuta I.C., Sauer J., and Bohndorf W. Omission of the pelvic irradiation in stage I testicular seminoma: A study of postorchiectomy paraaortic radiotherapy. Int J Radiat Oncol Biol Phys 35 (1996) 293-298
14. Hall E.J. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 65 (2006) 1-7
15. Sachs R.K., and Brenner D.J. Solid tumor risks after high doses of ionizing radiation. Proc Natl Acad Sci USA 102 (2005) 13040-13045
16. Dasu A., Toma-Dasu I., Olofsson J., et al. The use of risk estimation models for the induction of secondary cancers following radiotherapy. Acta Oncol 44 (2005) 339-347
17. Davis R.H. Production and killing of second cancer precursor cells in radiation therapy: In regard to Hall and Wuu (Int J Radiat Oncol Biol Phys 2003;56:83-88). Int J Radiat Oncol Biol Phys 59 (2004) 916
18. Schneider U., and Kaser-Hotz B. Radiation risk estimates after radiotherapy: Application of the organ equivalent dose concept to plateau dose-response relationships. Radiat Environ Biophys 44 (2005) 235-239
19. Kellerer A.M., Nekolla E.A., and Walsh L. On the conversion of solid cancer excess relative risk into lifetime attributable risk. Radiat Environ Biophys 40 (2001) 249-257
20. Hall E.J., and Wuu C.S. Radiation-induced second cancers: The impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 56 (2003) 83-88
21. Zagars G.K., Ballo M.T., Lee A.K., et al. Mortality after cure of testicular seminoma. J Clin Oncol 22 (2004) 640-647
22. Robinson D., Moller H., and Horwich A. Mortality and incidence of second cancers following treatment for testicular cancer. Br J Cancer 96 (2007) 529-533
23. Jacobsen G.K., Mellemgaard A., Engelholm S.A., et al. Increased incidence of sarcoma in patients treated for testicular seminoma. Eur J Cancer 29A (1993) 664-668
24. Li Y., Tabatabai Z.L., Lee T.L., et al. The Y-encoded TSPY protein: A significant marker potentially plays a role in the pathogenesis of testicular germ cell tumors. Hum Pathol 38 (2007) 1470-1481
25. Ullrich R.L. Etiology of cancer: Physical factors. In: DeVita R.T., Hellmann S., and Rosenberg S.A. (Eds). Cancer: principles and practice of oncology. 7th ed. Vol. 1 (2005), Lippincott Williams & Wilkins, Philadelphia 201-215
26. Fossa S.D., Chen J., Schonfeld S.J., et al. Risk of contralateral testicular cancer: A population-based study of 29,515 U.S. men. J Natl Cancer Inst 97 (2005) 1056-1066
27. Oliver R.T., Mason M.D., Mead G.M., et al. Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: A randomised trial. Lancet 366 (2005) 293-300
28. Martin J., Chung P., and Warde P. Treatment options, prognostic factors and selection of treatment in stage I seminoma. Onkologie 29 (2006) 592-598
29. Horwich A. Stage I seminoma. Onkologie 29 (2006) 554-555
30. Martin J.M., Panzarella T., Zwahlen D.R., et al. Evidence-based guidelines for following stage 1 seminoma. Cancer 109 (2007) 2248-2256
31. Martin J.M., Joon D.L., Ng N., et al. Towards individualised radiotherapy for stage I seminoma. Radiother Oncol 76 (2005) 251-256